UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 211

Sortiert nach

Management of gastric cancer in Asia: resource-stratified guidelines

The lancet oncology, 2013-11, Vol.14 (12), p.e535-e547

2013

Link zum Volltext

Verfügbarkeit prüfen

Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study

Gastrointestinal endoscopy, 2010-07, Vol.72 (1), p.25-32

2010

Link zum Volltext

Verfügbarkeit prüfen

Is the New Seventh AJCC/UICC Staging System Appropriate for Patients with Gastric Cancer?

Journal of the American College of Surgeons, 2012, Vol.214 (1), p.88-96

2012

Link zum Volltext

Verfügbarkeit prüfen

Management of gastric cancer: East vs west

Current problems in cancer, 2015-11, Vol.39 (6), p.315-341

Ryun Park, Sook, MD, PhD

2015

Link zum Volltext

Verfügbarkeit prüfen

Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer

Cancer, 2008-06, Vol.112 (11), p.2368-2376

2008

Link zum Volltext

Verfügbarkeit prüfen

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers

Journal of cancer education, 2020-06, Vol.35 (3), p.545-556

2020

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

The lancet oncology, 2014-11, Vol.15 (12), p.1389-1396

2014

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

BMC cancer, 2019-04, Vol.19 (1), p.292-292, Article 292

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

Oncoimmunology, 2024-12, Vol.13 (1), p.2371563

2024

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

Cancer science, 2010-03, Vol.101 (3), p.793-799

2010

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer

Journal of surgical oncology, 2008-10, Vol.98 (5), p.331-335

2008

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of Intraoperatively Estimated Surgical Stage in Curatively Resected Gastric Cancer Patients

Journal of the American College of Surgeons, 2009-10, Vol.209 (4), p.461-467

2009

Link zum Volltext

Verfügbarkeit prüfen

Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer

BMC cancer, 2021-04, Vol.21 (1), p.413-9, Article 413

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study

Liver cancer (Basel ), 2021-04, Vol.10 (2), p.107-114

2021

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study

Cancers, 2020-07, Vol.12 (7), p.1968

2020

Link zum Volltext

Verfügbarkeit prüfen

Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA

Nature communications, 2023-04, Vol.14 (1), p.2017-2017, Article 2017

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection

International journal of radiation oncology, biology, physics, 2012-12, Vol.84 (5), p.e585-e592

2012

Link zum Volltext

Verfügbarkeit prüfen

Detection and evaluation of signals for immune-related adverse events: a nationwide, population-based study

Frontiers in oncology, 2023, Vol.13, p.1295923-1295923

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY

Cancers, 2022-01, Vol.14 (3), p.559

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Preoperative Clinical Staging Assessed by Computed Tomography in Resectable Gastric Cancer Patients: A Viewpoint in the Era of Preoperative Treatment

Annals of surgery, 2010-03, Vol.251 (3), p.428-435

2010

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma

Hepatology communications, 2020-07, Vol.4 (7), p.1073-1086

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)

Journal for immunotherapy of cancer, 2024-03, Vol.12 (3), p.e008638

2024

Link zum Volltext

Verfügbarkeit prüfen

Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors in Cancer Treatment

Hematology/oncology clinics of North America, 2012-06, Vol.26 (3), p.649-670

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 211

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

ThemaMedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(198)

Publikationsform

Sprache

Englisch
(187)
Koreanisch
(24)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Management of gastric cancer in Asia: resource-stratified guidelines

Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study

Is the New Seventh AJCC/UICC Staging System Appropriate for Patients with Gastric Cancer?

Management of gastric cancer: East vs west

Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer

Prognostic Significance of Intraoperatively Estimated Surgical Stage in Curatively Resected Gastric Cancer Patients

Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer

Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study

Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09

Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study

Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA

Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection

A Functional Single Nucleotide Polymorphism in Mucin 1 , at Chromosome 1q22, Determines Susceptibility to Diffuse-Type Gastric Cancer

Detection and evaluation of signals for immune-related adverse events: a nationwide, population-based study

A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY

Prognostic Value of Preoperative Clinical Staging Assessed by Computed Tomography in Resectable Gastric Cancer Patients: A Viewpoint in the Era of Preoperative Treatment

Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma

Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)

Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors in Cancer Treatment

Aktive Filter

Suchergebnisse filtern